SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?


To: PSC who wrote (3996)4/8/1998 3:16:00 AM
From: Mr.Rich Nouveau  Respond to of 6136
 
As I understand it, AG3340, Agouron's MMP inhibitor, has completed Phase I trials and is about to enter phase II/III trials - perhaps IR could verify this. From what I hear in scientific circles (i.e., people looking for jobs), Agouron is hiring heavily in the drug discovery areas - this suggests they have a lot of projects going strong, which I think is good news for the pipeline.